{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:56:39Z","timestamp":1721915799555},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.11.066","type":"journal-article","created":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T16:27:00Z","timestamp":1198081620000},"page":"829-836","source":"Crossref","is-referenced-by-count":8,"title":["Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Shin","family":"Onodera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nishihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harukazu","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuharu","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.11.066_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","article-title":"Sex steroids and bone","volume":"57","author":"Manolagas","year":"2002","journal-title":"Recent Prog Horm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.066_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S8756-3282(01)00468-9","article-title":"The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood","volume":"29","author":"Rogers","year":"2001","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.066_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/er.23.1.90","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.066_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1359\/jbmr.1998.13.2.185","article-title":"IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice","volume":"13","author":"Van Bezooijen","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"5066","key":"10.1016\/j.vaccine.2007.11.066_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.vaccine.2007.11.066_bib8","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1073\/pnas.0407335101","article-title":"Postmenopausal osteoporosis, T cells, and immune dysfunction","volume":"101","author":"Teitelbaum","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"731","key":"10.1016\/j.vaccine.2007.11.066_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"Bloom","year":"1966","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.066_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.vaccine.2007.11.066_bib11","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.86.19.7522","article-title":"Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor","volume":"86","author":"Weiser","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6448","key":"10.1016\/j.vaccine.2007.11.066_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.066_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF03401892","article-title":"Localization of macrophage migration inhibitory factor (MIF) to secretory glanules within the corticotrophic and thyrotrophic cells of the pituitary gland","volume":"1","author":"Nishino","year":"1995","journal-title":"Mol Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.066_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1677\/joe.0.1790015","article-title":"Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation","volume":"179","author":"Baugh","year":"2003","journal-title":"J Endocrinol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.066_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI16288","article-title":"Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor","volume":"111","author":"Ashcroft","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0002-9440(10)61241-2","article-title":"Macrophage migration inhibitory factor: a central regulator of wound healing","volume":"167","author":"Hardman","year":"2005","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.066_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.febslet.2006.01.038","article-title":"Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss","volume":"580","author":"Oshima","year":"2006","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib19","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","article-title":"Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice","volume":"94","author":"Kitazawa","year":"1994","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.066_bib20","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/en.136.7.3054","article-title":"Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period","volume":"136","author":"Kimble","year":"1995","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice","volume":"12","author":"Kimble","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.22407","article-title":"A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis","volume":"56","author":"Onodera","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.066_bib25","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/eji.1830191209","article-title":"Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells","volume":"19","author":"Panina-Bordignon","year":"1989","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.066_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","article-title":"Gene transfer into muscle by electroporation in vivo","volume":"16","author":"Aihara","year":"1998","journal-title":"Nat Biotech"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.066_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00198-003-1437-9","article-title":"Melton LJ 3rd Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency","volume":"14","author":"Riggs","year":"2003","journal-title":"Osteoporosis Int"},{"issue":"8848","key":"10.1016\/j.vaccine.2007.11.066_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0140-6736(93)90571-W","article-title":"Prevention and treatment of osteoporosis","volume":"341","author":"Lindsay","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.066_bib30","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1359\/jbmr.060310","article-title":"Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis","volume":"21","author":"Onodera","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"47","key":"10.1016\/j.vaccine.2007.11.066_bib31","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2007.11.066_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2741\/1501","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis","volume":"10","author":"Morand","year":"2005","journal-title":"Front Biosci"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.066_bib33","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids","volume":"42","author":"Leech","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.10728","article-title":"Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis","volume":"48","author":"Morand","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.066_bib35","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","article-title":"Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency","volume":"110","author":"Weitzmann","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.066_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.0136772100","article-title":"IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells","volume":"100","author":"Toraldo","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.2002.1981","article-title":"Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice","volume":"20","author":"Shaughnessy","year":"2002","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.066_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s007740200038","article-title":"A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders","volume":"20","author":"Juji","year":"2002","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.066_bib40","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.4049\/jimmunol.175.9.6211","article-title":"Protection against osteoporosis by active immunization with TRANCE\/RANKL displayed on virus-like particles","volume":"175","author":"Spohn","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.066_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-3083.1997.d01-139.x","article-title":"High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study","volume":"46","author":"Jouvenne","year":"1997","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.066_bib42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/10878","article-title":"Therapeutic antibodies elicited by immunization against TNF-alpha","volume":"17","author":"Dalum","year":"1999","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.066_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1359-6101(03)00004-2","article-title":"Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases","volume":"14","author":"Zagury","year":"2003","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T03:34:03Z","timestamp":1557113643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07013734"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}